Login | Register

Psoriasis drug shows promise in diabetes trial

A drug previously used to treat psoriasis has shown positive results in a phase II trial assessing its effectiveness at treating type 1 diabetes, according to a study published in The Lancet Diabetes and Endocrinology. The drug, alefacept, is an immune-suppressing drug that has been used to treat psoriasis, a common skin condition, for around a decade...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *